share_log

Transcode Therapeutics | 8-K/A: Current report (Amendment)

Transcode Therapeutics | 8-K/A: Current report (Amendment)

Transcode Therapeutics | 8-K/A:重大事件(修正)
美股SEC公告 ·  06/14 08:04

Moomoo AI 已提取核心信息

TransCode Therapeutics, Inc. filed an amendment to its original Form 8-K report with the SEC to correct an error regarding the voting outcomes of its 2024 Annual Meeting of Shareholders, which took place on June 13, 2024. The amendment clarified that not all proposals were approved by the shareholders. During the meeting, four director nominees were elected, and the Stock Plan Amendment Proposal and the Auditor Proposal were approved. However, the Reverse Stock Split Proposal was not passed, and the Adjournment Proposal was approved without a subsequent motion to adjourn the meeting. The detailed voting results for each proposal were disclosed, including the number of votes for, against, abstentions, and broker non-votes where applicable.
TransCode Therapeutics, Inc. filed an amendment to its original Form 8-K report with the SEC to correct an error regarding the voting outcomes of its 2024 Annual Meeting of Shareholders, which took place on June 13, 2024. The amendment clarified that not all proposals were approved by the shareholders. During the meeting, four director nominees were elected, and the Stock Plan Amendment Proposal and the Auditor Proposal were approved. However, the Reverse Stock Split Proposal was not passed, and the Adjournment Proposal was approved without a subsequent motion to adjourn the meeting. The detailed voting results for each proposal were disclosed, including the number of votes for, against, abstentions, and broker non-votes where applicable.
TransCode Therapeutics,Inc.向美国证券交易委员会提交了一份修正版8-K表格报告,以更正其2024年股东年会投票结果的错误。该修正解释了并非所有提案都获得股东批准的事实。在会议期间,四位董事候选人当选,股票计划修正提案和审计提案均获批准。然而,反向股票拆分提案未能通过,而休会提案在没有随后的休会动议的情况下获得批准。详细的投票结果被披露,包括每个提案的赞成票数、反对票数、弃权票数和代理人未投票的情况(如适用)。
TransCode Therapeutics,Inc.向美国证券交易委员会提交了一份修正版8-K表格报告,以更正其2024年股东年会投票结果的错误。该修正解释了并非所有提案都获得股东批准的事实。在会议期间,四位董事候选人当选,股票计划修正提案和审计提案均获批准。然而,反向股票拆分提案未能通过,而休会提案在没有随后的休会动议的情况下获得批准。详细的投票结果被披露,包括每个提案的赞成票数、反对票数、弃权票数和代理人未投票的情况(如适用)。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息